title: The stony road to phe508del CFTR pharmacotherapy: smoothing the first rock.
authors: Clinic for Paediatric Pneumology, Allergology, and Neonatology, OE 6710, Hanover Medical School, D-30625 Hannover, Germany; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Centre for Lung Research, Hannover, Germany. Electronic address: tuemmler.burkhard@mh-hannover.de.
authors: Burkhard
authors: B
authors: Tümmler
mesh_terms: D000627:Aminophenols / Q000008:administration & dosage*; D000631:Aminopyridines / Q000008:administration & dosage*; D001483:Base Sequence; D052117:Benzodioxoles / Q000008:administration & dosage*; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000235:genetics*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D015363:Quinolones / Q000008:administration & dosage*; D017384:Sequence Deletion
chemical_list: D000627:Aminophenols; D000631:Aminopyridines; D052117:Benzodioxoles; C505032:CFTR protein, human; D015363:Quinolones; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C545203:ivacaftor; C569105:lumacaftor